{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006915",
      "entity_text" : "apoptosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:387447",
      "entity_text" : "Bortezomib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Bortezomib inhibits the 20S proteasome involved in the degradation of intracellular proteins, induces apoptosis, reverses drug resistance in multiple myeloma cells, and influences their microenvironment by blocking cytokine circuits, cell adhesion and angiogenesis in vivo.",
  "reading_complete" : "2020-08-05T22:29:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:25:20Z",
  "trigger" : "induces",
  "evidence" : [ "Bortezomib inhibits the 20S proteasome involved in the degradation of intracellular proteins, induces apoptosis" ],
  "pmc_id" : "3321668",
  "score" : 0
}